156 related articles for article (PubMed ID: 31867772)
1. Homozygosity for a novel large deletion in SLC29A3 in a patient with H syndrome.
Shankar SG; Rangarajan S; Priyadarshini A; Swaminathan A; Sundaram M
Pediatr Dermatol; 2020 Mar; 37(2):333-336. PubMed ID: 31867772
[TBL] [Abstract][Full Text] [Related]
2. Identification of two novel mutations in SLC29A3 encoding an equilibrative nucleoside transporter (hENT3) in two distinct Syrian families with H syndrome: expression studies of SLC29A3 (hENT3) in human skin.
Farooq M; Moustafa RM; Fujimoto A; Fujikawa H; Abbas O; Kibbi AG; Kurban M; Shimomura Y
Dermatology; 2012; 224(3):277-84. PubMed ID: 22653152
[TBL] [Abstract][Full Text] [Related]
3. Tocilizumab for the Treatment of SLC29A3 Mutation Positive PHID Syndrome.
Rafiq NK; Hussain K; Brogan PA
Pediatrics; 2017 Nov; 140(5):. PubMed ID: 29079714
[TBL] [Abstract][Full Text] [Related]
4. Novel homozygous SLC29A3 mutations among two unrelated Egyptian families with spectral features of H-syndrome.
Al-Haggar M; Salem N; Wahba Y; Ahmad N; Jonard L; Abdel-Hady D; El-Hawary A; El-Sharkawy A; Eid AR; El-Hawary A
Pediatr Diabetes; 2015 Jun; 16(4):305-16. PubMed ID: 24894595
[TBL] [Abstract][Full Text] [Related]
5. Variability in the Manifestations and Evolution of Symptoms in a Patient with H Syndrome.
Deshpande R; Parthasarathy L; Dalal A; Khadilkar V; Khadilkar A
Indian J Pediatr; 2016 Jan; 83(1):92-3. PubMed ID: 25967258
[No Abstract] [Full Text] [Related]
6. H syndrome - the first report in Malaysia.
Low DE; Tang MM; Surana U; Lee JY; Pramano ZAD; Leong KF
Int J Dermatol; 2019 Oct; 58(10):e190-e193. PubMed ID: 31192449
[No Abstract] [Full Text] [Related]
7. A novel homozygous frame-shift mutation in the SLC29A3 gene: a new case report and review of literature.
Noavar S; Behroozi S; Tatarcheh T; Parvini F; Foroutan M; Fahimi H
BMC Med Genet; 2019 Aug; 20(1):147. PubMed ID: 31464584
[TBL] [Abstract][Full Text] [Related]
8. H syndrome: Clinical, histological and genetic investigation in Tunisian patients.
Jaouadi H; Zaouak A; Sellami K; Messaoud O; Chargui M; Hammami H; Jones M; Jouini R; Chadli Debbiche A; Chraiet K; Fenniche S; Mrad R; Mokni M; Turki H; Benkhalifa R; Abdelhak S
J Dermatol; 2018 Aug; 45(8):978-985. PubMed ID: 29808591
[TBL] [Abstract][Full Text] [Related]
9. Ophthalmologic Findings in H Syndrome: A Unique Diagnostic Clue.
Molho-Pessach V; Mechoulam H; Siam R; Babay S; Ramot Y; Zlotogorski A
Ophthalmic Genet; 2015; 36(4):365-8. PubMed ID: 24547910
[TBL] [Abstract][Full Text] [Related]
10. SLC29A3 mutation in a patient with syndromic diabetes with features of pigmented hypertrichotic dermatosis with insulin-dependent diabetes, H syndrome and Faisalabad histiocytosis.
de Jesus J; Imane Z; Senée V; Romero S; Guillausseau PJ; Balafrej A; Julier C
Diabetes Metab; 2013 May; 39(3):281-5. PubMed ID: 23623699
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic intrafamilial variability including H syndrome and Rosai-Dorfman disease associated with the same c.1088G > A mutation in the SLC29A3 gene.
Chouk H; Ben Rejeb M; Boussofara L; Elmabrouk H; Ghariani N; Sriha B; Saad A; H'Mida D; Denguezli M
Hum Genomics; 2021 Oct; 15(1):63. PubMed ID: 34657628
[TBL] [Abstract][Full Text] [Related]
12. H syndrome: 5 new cases from the United States with novel features and responses to therapy.
Bloom JL; Lin C; Imundo L; Guthery S; Stepenaskie S; Galambos C; Lowichik A; Bohnsack JF
Pediatr Rheumatol Online J; 2017 Oct; 15(1):76. PubMed ID: 29041934
[TBL] [Abstract][Full Text] [Related]
13. An Egyptian family with H syndrome due to a novel mutation in SLC29A3 illustrating overlapping features with pigmented hypertrichotic dermatosis with insulin-dependent diabetes and Faisalabad histiocytosis.
Elbarbary NS; Tjora E; Molnes J; Lie BA; Habib MA; Salem MA; Njølstad PR
Pediatr Diabetes; 2013 Sep; 14(6):466-72. PubMed ID: 22989030
[TBL] [Abstract][Full Text] [Related]
14. Case of H syndrome with massive skin involvement, retroperitoneal fibrosis and Raynaud's phenomenon with a novel mutation in the SLC29A3 gene.
Fujita E; Komine M; Tsuda H; Adachi A; Murata S; Kamata Y; Minota S; Ohtsuki M
J Dermatol; 2015 Dec; 42(12):1169-71. PubMed ID: 26074390
[TBL] [Abstract][Full Text] [Related]
15. Clinical, Histochemical, and Molecular Study of Three Turkish Siblings Diagnosed with H Syndrome, and Literature Review.
Simsek E; Simsek T; Eren M; Yilmaz E; Arik D; Cilingir O; Ceylaner S; Harmancı K
Horm Res Paediatr; 2019; 91(5):346-355. PubMed ID: 30625464
[TBL] [Abstract][Full Text] [Related]
16. Progressive hearing loss associated with a unique cervical node due to a homozygous SLC29A3 mutation: a very mild phenotype.
Jonard L; Couloigner V; Pierrot S; Louha M; Gherbi S; Denoyelle F; Marlin S
Eur J Med Genet; 2012 Jan; 55(1):56-8. PubMed ID: 21888995
[TBL] [Abstract][Full Text] [Related]
17. Autoinflammation in addition to combined immunodeficiency: SLC29A3 gene defect.
Çağdaş D; Sürücü N; Tan Ç; Kayaoğlu B; Özgül RK; Akkaya-Ulum YZ; Aydınoğlu AT; Aytaç S; Gümrük F; Balci-Hayta B; Balci-Peynircioğlu B; Özen S; Gürsel M; Tezcan İ
Mol Immunol; 2020 May; 121():28-37. PubMed ID: 32151906
[TBL] [Abstract][Full Text] [Related]
18. Compound heterozygous SLC29A3 mutation causes H syndrome in a Moroccan patient: A case report.
Bakhchane A; Kindil Z; Charoute H; Benchikhi K; Khadir K; Nadifi S; Baline K; Roky R; Barakat A
Curr Res Transl Med; 2016; 64(2):65-8. PubMed ID: 27316388
[TBL] [Abstract][Full Text] [Related]
19. Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease.
Morgan NV; Morris MR; Cangul H; Gleeson D; Straatman-Iwanowska A; Davies N; Keenan S; Pasha S; Rahman F; Gentle D; Vreeswijk MP; Devilee P; Knowles MA; Ceylaner S; Trembath RC; Dalence C; Kismet E; Köseoğlu V; Rossbach HC; Gissen P; Tannahill D; Maher ER
PLoS Genet; 2010 Feb; 6(2):e1000833. PubMed ID: 20140240
[TBL] [Abstract][Full Text] [Related]
20. H syndrome treated with Tocilizumab: two case reports and literature review.
Jacquot R; Jouret M; Valentin MG; Richard M; Jamilloux Y; Rousset F; Emile JF; Haroche J; Steinmüller L; Zekre F; Phan A; Belot A; Seve P
Front Immunol; 2023; 14():1061182. PubMed ID: 37638031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
